0 0.25 0.5 0.75 1 1.25 1.5 1.75 2+ Reis (RCT) 2% 0.98 [0.06-15.6] death 1/569 1/557 low dose, data anomaly Improvement, RR [CI] Treatment Control Tau​2 = 0.00, I​2 = 0.0%, p = 0.99 Early treatment 2% 0.98 [0.06-15.6] 1/569 1/557 2% lower risk Aghasadeghi (RCT) 85% 0.15 [0.06-0.40] death 47 (n) 52 (n) Improvement, RR [CI] Treatment Control Shadnoush (DB RCT) -3% 1.03 [0.55-1.89] death 68 (n) 58 (n) ICU patients Tau​2 = 1.66, I​2 = 90.6%, p = 0.36 Late treatment 59% 0.41 [0.06-2.68] 115 (n) 110 (n) 59% lower risk All studies 51% 0.49 [0.10-2.25] 1/684 1/667 51% lower risk 3 spirulina COVID-19 studies c19early.org November 2024 Tau​2 = 1.33, I​2 = 81.4%, p = 0.36 Effect extraction pre-specified(most serious outcome) Favors spirulina Favors control
Sep 8
2024
Shadnoush et al., Journal of Cellular and Molecular Anesthesia, doi:10.5812/jcma-149015 Effects of Spirulina platensis Supplementation on COVID-19 Severity in Critically Ill Patients: A Randomized Clinical Trial
3% higher mortality (p=0.93), 26% shorter ICU admission (p=0.007), 17% lower need for oxygen therapy (p=0.64), and 20% shorter hospitalization (p=0.001). RCT 192 critically ill COVID-19 ICU patients showing reduced SOFA score, hospital stay and ICU stay with spirulina supplementation (5g/day), but no significant difference in mortality, NEWS2 score, APACHE score, NUTRIC score, or respirato..
Aug 15
2024
Reis et al., The American Journal of Clinical Nutrition, doi:10.1016/j.ajcnut.2024.06.016 Effect of spirulina on risk of hospitalization among patients with COVID-19: the TOGETHER randomized trial
21% higher progression (p=0.29). RCT 1,126 patients in Brazil showing no significant differences with low dose spirulina. The dose used was 7.6 times lower than the dose used by [Aghasadeghi] which shows significantly lower mortality. eFigure 1 shows 12 events in the tr..
Apr 8
2024
Aghasadeghi et al., Frontiers in Immunology, doi:10.3389/fimmu.2024.1332425 Effect of high-dose Spirulina supplementation on hospitalized adults with COVID-19: a randomized controlled trial
85% lower mortality (p=0.0002) and 75% higher hospital discharge (p=0.003). RCT 189 hospitalized COVID-19 patients showing lower mortality and faster recovery with spirulina. Spirulina treatment also resulted in greater reductions in inflammatory markers such as IL-6, TNF-a, IP-10, CRP, ESR, and ferritin. All pat..
Jul 31
2023
Rohilla et al., Stresses, doi:10.3390/stresses3030039 Algae Polysaccharides (Carrageenan and Alginate)—A Treasure-Trove of Antiviral Compounds: An In Silico Approach to Identify Potential Candidates for Inhibition of S1-RBD Spike Protein of SARS-CoV-2
In silico study showing the potential antiviral activity of algal polysaccharides alginate and carrageenan against SARS-CoV-2. Molecular docking analyses predict that alginate and carrageenan can bind to and inhibit the viral S1-RBD spike..
Jul 3
2023
Pantazopoulos et al., Journal of Personalized Medicine, doi:10.3390/jpm13071093 A Hypertonic Seawater Nasal Irrigation Solution Containing Algal and Herbal Natural Ingredients Reduces Viral Load and SARS-CoV-2 Detection Time in the Nasal Cavity
42% improved viral clearance (p=0.06). RCT 56 severe COVID-19 patients, showing significantly decreased viral load with Sinomarin Plus Algae nasal irrigation. Sinomarin Plus Algae is a hypertonic seawater solution with algal and herbal natural ingredients with a pH of 7.5-8..
May 30
2022
Mazokopakis et al., European Journal of Medical and Health Sciences, doi:10.24018/ejmed.2022.4.3.1355 The Contribution of Spirulina Platensis Supplementation on COVID-19 Prevention and Hospitalization
90% lower hospitalization (p<0.0001) and 81% fewer symptomatic cases (p<0.0001). Analysis of 186 adults in Greece showing a significant reduction in COVID-19 cases and hospitalizations with 6 g/day spirulina treatment for 6 months. Authors do not provide baseline details for each group.
Oct 25
2021
Leal-Martínez et al., International Journal of Environmental Research and Public Health, doi:10.3390/ijerph19031172 (date from preprint) Effect of a Nutritional Support System to Increase Survival and Reduce Mortality in Patients with COVID-19 in Stage III and Comorbidities: A Blinded Randomized Controlled Clinical Trial
86% lower mortality (p=0.03) and 57% lower ventilation (p=0.31). 80 patient RCT with 40 patients treated with a comprehensive regimen of nutritional support, showing significantly lower mortality with treatment. Treatment contained cholecalciferol, vitamin C, zinc, spirulina maxima, folic acid, glutami..